About Research at UPMC Hillman Cancer Center

For more than 30 years, UPMC Hillman Cancer Center has been committed to all aspects of cancer care.

The internationally renowned research at UPMC Hillman Cancer Center (formerly the University of Pittsburgh Cancer Institute) includes a range of disciplines, from cancer prevention and early detection to novel therapeutic discovery, survivorship, and end-of-life care.

As the only National Cancer Institute (NCI)-designated Comprehensive Cancer Center in western Pennsylvania, UPMC Hillman Cancer Center is making vast strides in the global effort to reduce the burden of cancer.

At UPMC Hillman Cancer Center, our researchers collaborate with our clinician-scientists to advance the most promising laboratory studies into novel clinical trials, providing patients with early access to new and innovated treatments. We are also dedicated to the education and training of the next generation of cancer researchers and physicians, and the ongoing recruitment of world-renowned scientists.

Research

Advancing our understanding of cancer through scientific discovery

Training

Preparing the next generation of researchers and clinicians

Community Outreach

Community Outreach

Educating the community on cancer prevention, treatment, and survivorship

Clinical Trials

Defining lifesaving approaches to prevent, diagnose, and treat cancer

Patients and Families

Learn about the conditions we treat, available therapies, and the UPMC Hillman Cancer Center difference

Upcoming Events

Jun
20
Thu
8:30 am Orthopedics/Pathology Tumor Board @ Radiology Conference Room, 1st floor, Posner Tower
Orthopedics/Pathology Tumor Board @ Radiology Conference Room, 1st floor, Posner Tower
Jun 20 @ 8:30 am – 9:30 am
Course director is Mark Goodman, MD
12:00 pm 2019 Senior Vice Chancellor’s La... @ Scaife Hall, Lecture Room 6
2019 Senior Vice Chancellor’s La... @ Scaife Hall, Lecture Room 6
Jun 20 @ 12:00 pm – 1:00 pm
This seminar series is open to the public, including all interested University of Pittsburgh and Carnegie Mellon University faculty, students, and staff. Arthur S. Levine, MD, Pitt’s senior vice chancellor for the health sciences and John and Gertrude Petersen Dean
Jun
21
Fri
9:15 am Melanoma Clinic Pathology Review... @ Shadyside Hospital, Department of Pathology, Room WG02.3
Melanoma Clinic Pathology Review... @ Shadyside Hospital, Department of Pathology, Room WG02.3
Jun 21 @ 9:15 am – 10:00 am
Every Friday from 9:15-10 am
12:00 pm Bridgeside Research Forum @ Bridgeside Point II Building, Room 503
Bridgeside Research Forum @ Bridgeside Point II Building, Room 503
Jun 21 @ 12:00 pm – 1:00 pm
The Bridgeside Research Forum is a seminar given by postdocs and graduate students every Friday from 12-1 pm during the academic year. Most weeks consist of two 30-minute talks, but there will be an occasional hour-long special seminar from an
12:00 pm Seminar @ Cooper Conference Rooms B/C, UPMC Hillman Cancer Center
Seminar @ Cooper Conference Rooms B/C, UPMC Hillman Cancer Center
Jun 21 @ 12:00 pm – 1:00 pm
Flier
1:00 pm 2019 Advances in Cancer Immunoth... @ Herberman Conference Center, Room 202A, Cancer Pavilion, Shadyside Hospital
2019 Advances in Cancer Immunoth... @ Herberman Conference Center, Room 202A, Cancer Pavilion, Shadyside Hospital
Jun 21 @ 1:00 pm – 5:00 pm
Flier Please join us for our second annual ITTC/UPMC advances in cancer immunotherapy meeting. Refreshments will be provided. Herberman Conference Center, Room 202A, Second Floor Cancer Pavilion, UPMC Shadyside Hospital, Pittsburgh, PA To register, contact Darren Gilmartin at gilmartind@upmc.edu or

Robert Ferris

 

Director’s Message

Robert L. Ferris, MD, PhD

UPMC Hillman Cancer Center (Hillman) is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center and the preeminent institution in western Pennsylvania for providing cancer care; conducting basic, translational, clinical, and population science research; and educating the next generation of cancer researchers and physicians.

At Hillman, we are quickly advancing the latest research discoveries into pioneering therapies that can benefit the more than 110,000 patients seen each year throughout our integrated cancer care delivery network. Read more in our June 2019 Director's message.